BC Week In Review | Oct 31, 2011
Company News

Cytokine PharmaSciences, Ferring deal

Ferring acquired Cytokine and its Controlled Therapeutics Ltd. subsidiary. The deal includes Controlled Therapeutics' manufacturing facilities for uterine contraction drug dinoprostone, which Forest Laboratories Inc. (NYSE:FRX, New York, N.Y) markets as Cervidil in the U.S....
BC Week In Review | Jul 30, 2007
Clinical News

Isoprelor misoprostol: Phase III data

In the European Phase III APL202 001/2 trial in 626 women, there was no difference between Isprelor and dinoprostone in the ability to produce a vaginal delivery within 24 hours of starting treatment. Nausea was...
BC Week In Review | Jan 17, 2005
Clinical News

Misoprostol: Started Phase III

APH began U.K. Phase III trial comparing APL202 with dinoprostone in 1,012 women who have had a first baby delivered without complications. Alliance Pharma plc (LSE:APH), Chippenham, U.K.   Business: Genitourinary   Product: Misoprostol ( APL202...
Items per page:
1 - 3 of 3